Evidence map›Paper›PMID 40730732›Full record

ArticleAnnals of surgical oncology2025

Correction: Natural History of Primary Retroperitoneal Extra-Visceral Perivascular Epithelioid Cell Tumors (PEC): A Study from Transatlantic and Australasian Retroperitoneal Sarcoma Working Group (TARPSWG).

Eyal Mor, Sameer Apte, Catherine Mitchell, Carolyn Nessim, Max Almond, Bruno Vincenzi, Jose Antonio Gonzalez Lopez, Lee Cranmer, Michael J Wagner, Aviram Nissan and 9 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Eyal MorSir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia.ORCID http://orcid.org/0000-0002-3235-2946
Sameer ApteSir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia.
Catherine MitchellSir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, VIC, Australia.
Carolyn NessimUniversity of Ottawa, Ottawa, Canada.
Max AlmondUniversity Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Bruno VincenziUniversità Campus Bio-Medico, Rome, Italy.
Jose Antonio Gonzalez LopezHospital de Sant Pau, Barcelona, Spain.
Lee CranmerUniversity of Washington, Seattle, WA, USA.
Michael J WagnerDana-Farber Cancer Institute, Boston, MA, USA.
Aviram NissanSheba Medical Center, Ramat-Gan, Israel.
Miguel Henriques AbreuPortuguese Institute of Oncology of Porto, Porto, Portugal.
Markus AlbertsmeierLudwig-Maximilians-Universität (LMU) Munich, LMU University Hospital, Munich, Germany.
Mathilda KnoblauchLudwig-Maximilians-Universität (LMU) Munich, LMU University Hospital, Munich, Germany.
Adam BarlowLeeds Teaching Hospitals NHS Trust, Leeds, UK.
Emily Z KeungThe University of Texas MD Anderson, Houston, TX, USA.
Giovanni GrignaniCandiolo Cancer Institute, FPO-IRCCS, Candiolo, TO, Italy.
Jason L HornickBrigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Alessandro GronchiFondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
David E GyorkiDivision of Cancer Surgery, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. David.gyorki@petermac.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40730732
PMCPMC12454578

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.